How to Buy Globus Medical Stock

Globus Medical Inc

Globus Medical is a medical device company located in Pennsylvania, United States, which is part of the Healthcare sector, and is traded under the ticker GMED on the NYSE exchange.

Globus Medical stock last closed at $86.70, down 2.45% from the previous day, and has increased 4.82% in one year. It has overperformed other stocks in the Medical Devices industry by 0.37 percentage points. Globus Medical stock is currently +67.41% from its 52-week low of $51.79, and -8.67% from its 52-week high of $94.93.

There are currently 133.84M GMED shares outstanding. The market value of GMED is $11.60B. In the last 24 hours, 1.4M GMED shares were traded.

How to Buy Globus Medical Stock

Wondering how to invest in Globus Medical stock? Here's how.

  1. Choose where to buy Globus Medical stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Globus Medical stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit money your investment account: Pick your payment method and add your info.
  4. Research Globus Medical stock: The Globus Medical ticker symbol is GMED. Is Globus Medical stock a good investment? Should you buy shares of GMED? How do GMED's underlying business fundamentals look? Do top analysts think Globus Medical is a good buy? Why has GMED's stock price moved recently? (Hint: Our stock market research website can help you evaluate if GMED is a good stock to buy).
  5. Make your GMED trade: Decide if you will purchase GMED shares at the current market price or use a limit order to purchase GMED shares at a particular price.
  6. Keep an eye on your GMED position: Create a watchlist to get live updates on your new investment in Globus Medical shares.

Step 1: Choose where to buy Globus Medical stock

You need a brokerage account to access the NYSE market and buy GMED shares.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our research, eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world financial markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've picked your brokerage, you'll need to fill out some personal information so you can buy GMED today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new trading account.
  1. Send your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you've filled out your info on apps for stock market, your next step is to transfer the money for your investment:

Watch the walkthrough below for more details depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Globus Medical stock

Once you have decided on the best place to buy Globus Medical stock, it's critical to analyze their stock prior to investing, so you actually wrap your head around the risk as well as the upside.

Globus Medical stock at a glance

GMED Price
$86.70
1w %
-4.83%
1y %
4.82%
5y %
39.86%
P/E
27.7x
P/B
2.64x
P/S
4.21x
PEG
2.07x
Revenue
$2.77B
Earnings
$423.78M
Fore. Rev. Growth
6.98%
Fore. Earn. Growth
13.35%
Market Cap
$11.60B
Next Earnings
N/A
Next Dividend
N/A

GMED Fundamentals

WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on GMED's stock page.

How is GMED stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge GMED's fair value.

Using relative valuations methods:

  • GMED may be overvalued based on its P/E ratio of 27.7x, relative to Medical Devices industry P/E ratio of 24.46x
  • GMED could be undervalued based on its P/B ratio of 2.64x, relative to Medical Devices industry P/B ratio of 3.88x
  • GMED may be overvalued based on its PEG ratio of 2.07x

You can access additional valuation analysis on GMED's stock here.

How do GMED Financials look?

Pros:

  • There are more short-term assets than short-term liabilities on the GMED balance sheet.
  • GMED profit margin has gone up from 3.7% to 15.3% in the past year.
  • There are more short-term assets than long-term liabilities on the GMED balance sheet.
  • GMED's operating cash flow of $715.20M allows it to safely service it's debt of $119.34M.
  • GMED earnings of $455.86M is not sufficient to cover its interest payments.
  • GMED has a low debt to equity ratio of 0.16.

Cons:

  • Total GMED debt is higher than 5 years ago, relative to shareholder equity.

Do analysts think it's a good time to buy Globus Medical stock

Out of 8 sell side analysts who give recommendations on GMED, the consensus analyst rating on Globus Medical is a Strong Buy

It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.

Latest GMED Analyst Recommendations

Craig Bijou, a top 8% analyst from Bank of America upgrades GMED to a strong buy rating and raises their GMED price target from $65.00 to $91.00, on Nov 7, 2025.

Bank of America's Craig Bijou upgraded their rating on Globus Medical (NYSE: GMED) from Hold to Strong Buy on 2025/11/07. The analyst also raised their price target by 40% from $65 to $91.

Globus Medical reported its Q3 2025 earnings.

Upgrading the stock and hiking their price target, Bijou headlined that the quarter set records for revenue, earnings, and cash flow.

The analyst specifically cited Globus Medical's capacity to deliver compounded profits and cash flow for their upgrade from Hold to Strong Buy.

The stock's valuation is "not stretched" at current levels, Bijou told readers.

Earnings Report

For Q3 2025, Globus Medical reported:

  • EPS of $1.18, which beat the Zacks Consensus Estimate of $0.79 and Q3 2024's $0.83.
  • Revenue of $769.05M, which beat the Zacks Consensus Estimate by 4.85% and Q3 2024's $625.71M.

Management did not provide financial guidance in its press release.

President & CEO Keith Pfeil reported: “We are pleased with the strength of our overall results and continued progress throughout the company.

“Q3 revenue rose 23%, driven by 10% growth in our US Spine business, as momentum accelerated during the quarter with broad-based demand across our products and geographies.

"Our recently acquired Nevro business continued to exceed expectations, underscoring the strength of our integration strategy, as we position this business for future growth.

"Strength in revenue translated into enhanced earnings and profitability, with meaningful improvements in adjusted gross margins and operating expenses, reflecting both synergy capture and operating leverage from the NuVasive merger and Nevro acquisition.

"Looking ahead, we remain focused on finishing 2025 strong, with a clear path toward consistent organic growth through innovation, disciplined execution, and delivering differentiated technologies that improve patient outcomes.”

Thomas Stephan, a top 21% analyst from Stifel Nicolaus reinstates GMED with a hold rating and announces their GMED price target of $64.00, on Oct 28, 2025.

William Plovanic, a top 11% analyst from Canaccord Genuity maintains GMED with a strong buy rating and lowers their GMED price target from $97.00 to $90.00, on Jul 22, 2025.

You can dig deeper into what analysts are saying on the Globus Medical stock forecast page.

Metrics for Advanced GMED Traders

SMA10
88.72
SMA20
87.61
SMA50
73.82
SMA100
65.86
SMA200
65.71
MACD
3.98
MACD Signal
5.1
MACD Histogram
-1.12
RSI
58.22
Stochastic %K
44.09
Stochastic %D
55.39
StochRSI %K
3.58
StochRSI %D
2.39

Is GMED Growing Revenue?

Last year, GMED earnings were $423.78M. During the past five year, GMED's earnings have grown by 26.66% per year. This was faster than the Medical Devices industry average of 14.21%.

Last year, GMED revenue was $2.77B. In the last 5 year, GMED's revenue has increased by 29.27% per year. This was faster than the Medical Devices industry average of 10.92%.

Dig into GMED's earnings and revenue performance here.

Are GMED executives and large shareholders buying or selling the stock?

Over the last year, executives and large shareholders at GMED have bought more shares than they have sold.

David C. Paul, Executive Chairman of GMED, was the latest GMED insider to buy. They bought $877,250.00 worth of GMED stock on Dec 8, 2025.

Research more about who owns GMED stock here.

Does GMED stock generate passive income?

No, Globus Medical doesn't provide an income stream by paying out dividends.

What do other investors have to say about GMED?

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Make your GMED trade

There are two main order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are generally fine.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at an exact dollar amount limit, use a limit order.

Click the Open button and eToro will execute the order.

If you require additional assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep an eye on your GMED position

Now that you own some GMED stock, you'll want to keep up with your investment.

Create a watchlist to track the most important metrics related to your GMED stock.

GMED Feed

How to Buy Stock in Globus Medical

To reiterate, here are the 6 steps you need to take to buy Globus Medical stock right now:

  1. Choose where to buy Globus Medical stock
  2. Sign up for your brokerage account
  3. Deposit money your investment account
  4. Research Globus Medical stock
  5. Make your GMED trade
  6. Keep an eye on your GMED position

If you need a online brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your investment in Globus Medical, click below.

NYSE: GMED
$86.70-2.18 (-2.45%)
Updated Dec 12, 2025
Open eToro Account
Your capital is at risk.
NYSE: GMED
$86.70-2.18 (-2.45%)
Updated Dec 12, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Globus Medical share?

As of Dec 12, 2025, it costs $86.70 to buy one share of Globus Medical stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.115 shares of GMED.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Globus Medical stock?

According to 8 Wall Street analysts who monitor Globus Medical, their consensus recommendation is to buy Globus Medical stock.

What is the best way to buy Globus Medical stock?

One way to place an order for Globus Medical stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.